EMPATHERAPY: Next generation of PERSONALISED digital, blended and self-help therapy to treat anxiety and depression, and improve wellbeing

移情疗法：下一代个性化数字、混合和自助疗法，用于治疗焦虑和抑郁并改善健康

• 批准号: 86260
• 金额: $ 12.12万
• 依托单位: MINDLIFE UK LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=86260
• 关键词: EMPATHERAPY; Next; generation; PERSONALISED; digital

At least one in five adults suffer from anxiety, depression, and Covid-19 has increased the population of sufferers. About 7m sufferers are receiving antidepressants and other medications which don't cure them and have side-effects. About 1.6m are referred annually to NHS psychotherapy (called IAPT), mainly face-to-face therapy (until covid-19). However, because of limitations of budgets and therapists patients are receiving only, on average, 6.9 sessions, and only 0.3m recover. The existing methods and number of therapists cannot cope with the increased demand.Because of covid-19 therapists have switched to remote therapy, mainly by telephone or video call, which made the situation worse.There are some existing digital solutions, but they are not personalised and only about 5% of therapists are using them.In the last three years MindLife has collaborated with leading experts and NHS Mental-Health Trusts to research more effective methods, to assess, and treat patients, by combining digital interventions, AI/Machine-Learning with advanced psychological science, including:--Analysis of thousands of patients' anonymised data (using Artificial Intelligence /Machine-Learning). We've developed and tested intelligent algorithms which analyse the user's conditions, needs and progress, and refer him/her to the most effective and relevant type of therapy and therapist available.--Our digital platform (UpLiftNOW) which enables us and therapists to create appealing interactive self-help applications which can teach the users and empower them to practise in their daily lives relevant interventions according to their needs.--Computerised algorithms which assess the user's progress every session and provides feedback to the therapist about the probability of patient recovery and whether he/she should change course to make it more effective.--We've developed digital platforms Ai-Leap, to deliver therapy which enabling therapists to combine face-to-face or remote therapy with digital self-help app which the patient can use during, between and after sessions.We tested these innovations in RCTs but we didn't have the time and funds to integrate and implement them in NHS IAPT services.In this EMPATHERAPY project we will integrate all the above interventions and tools, upgrade them to create effective, personalised digital therapy and implement it in NHS services to improve outcome and patient wellbeing.EMPATHERAPY will be the next generation of mental-health therapy. It will combine the best of the human therapists, who will provide empathy, motivation, hope and advice, using his/her own experience and knowledge, together with expertise and knowledge accumulated from thousands of patients, analysed by experts and AI/Machine-Learning. The patient will receive, in addition to the therapy session, many interactive sessions and Skills Practices which will enable him to implement what he/she has learned in his/her daily life and progress much faster to recover and improve his/her life.EMPATHERAPY will revolutionize the mental-health therapy to improve the lives of millions in the UK and globally. It will enable MindLife to export the Software-as-a-Service, internationally, bring income to the UK, and repay the taxpayer much more than this initial investment.

至少有五分之一的成年人患有焦虑、抑郁症，新冠肺炎增加了患者人数。大约有700万患者正在接受抗抑郁药和其他药物治疗，这些药物不能治愈他们，而且有副作用。每年约有160万人接受NHS心理治疗（称为IAPT），主要是面对面治疗（直到新冠肺炎）。然而，由于预算和治疗师的限制，患者平均只接受6.9次治疗，只有30万人康复。现有的治疗方法和治疗师的数量无法科普日益增长的需求。由于新冠肺炎，治疗师转向远程治疗，主要通过电话或视频通话，这使情况变得更糟。现有的一些数字解决方案，但它们并不是个性化的，只有大约5%的治疗师在使用它们。在过去的三年里，MindLife与领先的专家和NHS Mental合作，健康信托研究更有效的方法，通过将数字干预，人工智能/机器学习与先进的心理科学相结合来评估和治疗患者，包括：-分析数千名患者的匿名数据（使用人工智能/机器学习）。我们已经开发并测试了智能算法，可以分析用户的状况，需求和进展，并将他/她推荐给最有效和最相关的治疗和治疗师。我们的数字平台（UpLiftNOW）使我们和治疗师能够创建有吸引力的互动自助应用程序，这些应用程序可以教导用户并使他们能够根据自己的需求在日常生活中实践相关干预措施。计算机化的算法，评估用户每次会话的进展，并向治疗师提供有关患者康复概率的反馈，以及他/她是否应该改变课程以使其更有效。我们已经开发了数字平台Ai-Leap，以提供治疗，使治疗师能够将联合收割机面对面或远程治疗与数字自助应用程序相结合，患者可以在治疗期间，治疗期间和治疗后使用。我们在RCT中测试了这些创新，但我们没有时间和资金将其整合和实施到NHS IAPT服务中。在这个EMPATHERAPY项目中，我们将整合所有上述干预措施和工具，升级它们以创建有效的、个性化的数字治疗，并在NHS服务中实施，以改善结果和患者福祉。EMPATHERAPY将成为下一代心理健康治疗。它将结合联合收割机最好的人类治疗师，他们将利用自己的经验和知识，以及从数千名患者中积累的专业知识和知识，通过专家和人工智能/机器学习进行分析，提供同理心，动机，希望和建议。除了治疗课程外，患者还将接受许多互动课程和技能练习，这将使他/她能够在日常生活中实施他/她所学到的知识，并更快地恢复和改善他/她的生活。EMPATHERAPY将彻底改变心理健康治疗，以改善英国和全球数百万人的生活。这将使MindLife能够在国际上出口软件即服务，为英国带来收入，并偿还纳税人远远超过最初的投资。